Biodegradable and Sustainable Synthetic Antibodies-A Perspective
Molecular imprinting technology has been around for almost a century, and we have witnessed dramatic advancements in the overall design and production of molecularly imprinted polymers (MIPs), particularly in terms of possible formats of the final products when it comes to truly resembling antibody...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_33fbc31dc02e4efb8e5a5d4f3ddd38e8 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Xiaohan Ma |e author |
700 | 1 | 0 | |a Jonathan C. Knowles |e author |
700 | 1 | 0 | |a Alessandro Poma |e author |
245 | 0 | 0 | |a Biodegradable and Sustainable Synthetic Antibodies-A Perspective |
260 | |b MDPI AG, |c 2023-05-01T00:00:00Z. | ||
500 | |a 10.3390/pharmaceutics15051440 | ||
500 | |a 1999-4923 | ||
520 | |a Molecular imprinting technology has been around for almost a century, and we have witnessed dramatic advancements in the overall design and production of molecularly imprinted polymers (MIPs), particularly in terms of possible formats of the final products when it comes to truly resembling antibody substitutes, i.e., MIP nanoparticles (MIP NPs). Nonetheless, the overall technology appears to struggle to keep up with the current global sustainability efforts, as recently elucidated in the latest comprehensive reviews, which introduced the "GREENIFICATION" concept. In this review, we will try to elucidate if these advancements in MIP nanotechnology have indeed resulted in a sustainability amelioration. We will do so by discussing the general production and purification strategies for MIP NPs, specifically from a sustainability and biodegradation perspective, also considering the final intended application and ultimate waste management. | ||
546 | |a EN | ||
690 | |a molecular imprinting | ||
690 | |a molecularly imprinted polymers | ||
690 | |a nanoparticles | ||
690 | |a synthetic antibodies | ||
690 | |a biodegradable polymers | ||
690 | |a sustainable imprinting | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceutics, Vol 15, Iss 5, p 1440 (2023) | |
787 | 0 | |n https://www.mdpi.com/1999-4923/15/5/1440 | |
787 | 0 | |n https://doaj.org/toc/1999-4923 | |
856 | 4 | 1 | |u https://doaj.org/article/33fbc31dc02e4efb8e5a5d4f3ddd38e8 |z Connect to this object online. |